Jan 11 2011

Victoria Rudenko, OMS IV and Linda Friedman, Ph.D., Associate Professor, Department of Neuroscience/Histology, attended the 2010 Annual American Epilepsy Society Convention and presented a poster entitled “Inverse Relationship of Cannabimimetic (R+)WIN55, 212 on Behavior and Seizure Threshold during the Juvenile Period.”
Low doses abolished seizures which may be a groundbreaking therapeutic strategy to treat early-life seizures without side effects. Immunohistochemical studies suggested that the CB1 receptor subunit is responsible for the does-dependent effects. First year medical student, Asfi Rafiuddin, co-authored the posteralong with Victoria and Dr. Friedman.